ARTICLE | Company News
Orion, Eisai sales and marketing update
July 25, 2011 7:00 AM UTC
Eisai received Chinese marketing rights to Orion's breast cancer drug Fareston toremifene citrate and Parkinson's disease (PD) drug Eldepryl selegiline. Fareston, a non-steroidal selective estrogen r...